Ryan Maynard - 01 Mar 2023 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
Chief Financial Officer
Signature
Darren DeStefano, Attorney-in-Fact
Issuer symbol
CARA
Transactions as of
01 Mar 2023
Transactions value $
$0
Form type
4
Filing time
03 Mar 2023, 15:38:07 UTC
Previous filing
14 Sep 2022
Next filing
08 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARA Stock Option (Right to Buy) Award $0 +81K $0.00 81K 01 Mar 2023 Common Stock 81K $10.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 1, 2023, in each case subject to the Reporting Person's continued service as of each such date.